Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.
Funding
Debt: $300.0M. Last 2 years.
Debt: $300M (not counted as a raise), announced Jun 17, 2026. Source: SEC filing. source ↗
ImmuneRACE - Immune Response Action to COVID-19 Events
Not listed
Completed
Apr 24, 2020
Mar 23, 2021 (actual)
NIH awards 9
Annual award amounts. Total $4.0M.
NIH award 4R44HL106868-04 FY2017: $519,759 awarded for that fiscal year; activity R44 (SBIR); PI EMERSON, RYAN O; recipient as written: ADAPTIVE BIOTECHNOLOGIES CORPORATION, SEATTLE, WA. Correlating TCR diversity to source ↗
NIH award 5R44HL106868-03 FY2015: $1,057,509 awarded for that fiscal year; activity R44 (SBIR); PI RIEDER, MARK J; recipient as written: ADAPTIVE BIOTECHNOLOGIES CORPORATION, SEATTLE, WA. Correlating TCR diversity to source ↗
NIH award 1R43AI112125-01 FY2014: $244,699 awarded for that fiscal year; activity R43 (SBIR); PI RIEDER, MARK J; recipient as written: ADAPTIVE BIOTECHNOLOGIES CORPORATION, SEATTLE, WA. Non-invasive Diagnostic Platfo source ↗
NIH award 2R44HL106868-02 FY2013: $951,199 awarded for that fiscal year; activity R44 (SBIR); PI RIEDER, MARK J; recipient as written: ADAPTIVE BIOTECHNOLOGIES CORPORATION, SEATTLE, WA. Correlating TCR diversity to i source ↗
NIH award 1R43CA167972-01A1 FY2013: $165,191 awarded for that fiscal year; activity R43 (SBIR); PI RIEDER, MARK J; recipient as written: ADAPTIVE BIOTECHNOLOGIES CORPORATION, SEATTLE, WA. Minimal Residual Disease Mon source ↗
NIH contract (government contract; not a grant and not an investment round) 261201300037C-0-0-1 FY2013: $266,199 awarded for that fiscal year; activity N43 (OTHER_NIH); PI RIEDER, MARK; recipient as written: ADAPTIVE BIOTECHNOLOGIES CORPORATION, SEATTLE, WA. A source ↗
NIH award 5R43DK089783-02 FY2011: $299,915 awarded for that fiscal year; activity R43 (SBIR); PI LIVINGSTON, ROBERT J; recipient as written: ADAPTIVE BIOTECHNOLOGIES CORPORATION, SEATTLE, WA. Development of T-cell re source ↗
NIH award 1R43HL106868-01A1 FY2011: $148,999 awarded for that fiscal year; activity R43 (SBIR); PI LIVINGSTON, ROBERT J; recipient as written: ADAPTIVE BIOTECHNOLOGIES CORPORATION, SEATTLE, WA. Correlating TCR divers source ↗
NIH award 1R43DK089783-01 FY2010: $332,770 awarded for that fiscal year; activity R43 (SBIR); PI LIVINGSTON, ROBERT J; recipient as written: ADAPTIVE BIOTECHNOLOGIES CORPORATION, SEATTLE, WA. Development of T-cell re source ↗
